Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Amarin Corporation PLC (AMRN)

NASDAQ
Currency in USD
0.524
-0.002(-0.30%)
Real-time Data
AMRN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.5070.527
52 wk Range
0.4571.370
Key Statistics
Edit
Prev. Close
0.526
Open
0.515
Day's Range
0.507-0.527
52 wk Range
0.457-1.37
Volume
448.66K
Average Vol. (3m)
994.54K
1-Year Change
-29.87%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AMRN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1.000
Upside
+92.678%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year
Show more

Amarin Corporation PLC Company Profile

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Compare AMRN to Peers and Sector

Metrics to compare
AMRN
Peers
Sector
Relationship
P/E Ratio
−5.5x−5.2x−0.7x
PEG Ratio
−0.25−0.150.00
Price / Book
0.4x3.0x2.6x
Price / LTM Sales
0.9x41.8x3.2x
Upside (Analyst Target)
90.1%49.0%43.2%
Fair Value Upside
Unlock0.8%6.8%Unlock

Analysts' Recommendations

0 Buy
1 Hold
2 Sell
Ratings:
2 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 1.000

(+90.84% Upside)

People Also Watch

2.625
BZUN
-5.23%
2.045
GRWG
-1.68%
38.45
APPN
-1.07%
2.1400
FOSL
-8.94%
6.640
SIGA
-7.13%

FAQ

What Is the Amarin (AMRN) Stock Price Today?

The Amarin stock price today is 0.524

What Stock Exchange Does Amarin Trade On?

Amarin is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Amarin?

The stock symbol for Amarin is "AMRN."

What Is the Amarin Market Cap?

As of today, Amarin market cap is 216.24M.

What is Amarin Earnings Per Share?

The Amarin EPS is -0.096.

What Is the Next Amarin Earnings Date?

Amarin will release its next earnings report on Feb 26, 2025.

From a Technical Analysis Perspective, Is AMRN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.